Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
KRRO
#3224
Korro Bio, Inc. Common Stock
12.130
0
+4.39%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
+4.39%
Monatliche Änderung
+6.22%
6 month change
-68.82%
Jahresänderung
-68.82%
Vorheriger Schlusskurs
11.620
0
Open
12.130
0
Bid
Ask
Low
12.130
0
High
12.130
0
Volumen
27
Märkte
Aktien
Gesundheitswesen
KRRO
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
9.37 M
9.39 M
9.39 M
9.39 M
9.42 M
—
Valuation ratios
Enterprise value
249.88 M
301.79 M
99.34 M
83.68 M
426.84 M
911.66 M
Price to earnings ratio
0.24
-4.06
-1.85
-1.28
-5.1
-12.29
Price to sales ratio
—
149.54
—
—
60.02
—
Price to cash flow ratio
1.68
5.65
2.56
1.73
6.54
16.48
Price to book ratio
0.06
0.49
0.06
0.04
0.15
0.74
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.09
0.09
0.12
0.14
0.11
0.46
Return on equity %
0.12
0.13
0.17
0.22
0.18
0.71
Return on invested capital %
-102.59
-71.83
-81.21
-127.88
-99.97
-380.89
Gross margin %
—
100
100
100
100
400
Operating margin %
—
-1 014.53
-981.18
-1 863.15
-1 764.86
-5 623.72
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
933.47
917.14
1 765.07
1 656.97
5 272.64
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
11.23
8.79
9.41
5.98
6.71
30.89
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
0.01
0.01
0.01
0.01
0.04
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
1.83
0.84
2.61
2.05
1.83
7.32
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
15.62
6.24
12.25
10.27
9.85
38.6
Net current asset value per share
17.42
14.74
12.92
10.93
10.46
49.06
Tangible book value per share
76.43
77.72
76.61
79.53
81.65
315.52
Working capital per share
15.87
13.07
11.55
9.1
8.9
42.62
Book value per share
76.43
77.72
76.61
79.53
81.65
315.52
Nachrichten
Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates
Clear Street stuft Korro-Bio-Aktie hoch – Potenzial bei Hyperammonämie-Programm
Clear Street upgrades Korro Bio stock rating on hyperammonemia program potential
Strength Seen in Korro Bio, Inc. (KRRO): Can Its 13.9% Jump Turn into More Strength?
Korro Bio: H.C. Wainwright stuft Aktie wegen neuem Medikamentenpotenzial auf "Buy" hoch
Korro Bio stock rating upgraded by H.C. Wainwright to Buy on new drug potential
Piper Sandler stuft Korro Bio auf "Overweight" hoch – Hoffnung auf UCD-Therapie
Piper Sandler upgrades Korro Bio stock rating to Overweight on UCD treatment
Chardan Capital upgrades Korro Bio stock to Buy on KRRO-121 potential
Korro Bio, Inc. (KRRO) Analyst/Investor Day - Slideshow (NASDAQ:KRRO) 2026-01-28
Korro Bio: William Blair bestätigt "Market Perform"-Rating nach neuen Studiendaten
Raymond James bestätigt ’Market Perform’-Rating für Korro Bio-Aktie